• Users Online:550
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
IMAGES AND VIDEOS
Year : 2018  |  Volume : 7  |  Issue : 1  |  Page : 64-66

A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection


1 Department of Medicine, Division of Gastroenterology, School of Medicine, Kurume University, Kurume, Japan
2 Department of Surgery, School of Medicine, Kurume University, Kurume, Japan
3 Department of Diagnostic Pathology, School of Medicine, Kurume University, Kurume, Japan

Date of Submission31-Mar-2017
Date of Acceptance03-Jul-2017
Date of Web Publication15-Feb-2018

Correspondence Address:
Dr. Yoshinobu Okabe
Department of Medicine, Division of Gastroenterology, School of Medicine, Kurume University, 67 Asahi-Machi, Kurume City, Fukuoka 830-0011
Japan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/eus.eus_58_17

Rights and Permissions

How to cite this article:
Yasumoto M, Okabe Y, Ishikawa H, Kisaki J, Akiba J, Naito Y, Ishida Y, Ushijima T, Tsuruta O, Torimura T. A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection. Endosc Ultrasound 2018;7:64-6

How to cite this URL:
Yasumoto M, Okabe Y, Ishikawa H, Kisaki J, Akiba J, Naito Y, Ishida Y, Ushijima T, Tsuruta O, Torimura T. A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection. Endosc Ultrasound [serial online] 2018 [cited 2020 Apr 5];7:64-6. Available from: http://www.eusjournal.com/text.asp?2018/7/1/64/225431



The patient was a 78-year-old woman in whom abdominal ultrasonography in a medical examination revealed dilatation of the main pancreatic duct. She, therefore, attended our hospital. Computed tomography (CT) [Figure 1] and magnetic resonance imaging (MRI) revealed a mass lesion 10 mm in diameter in the pancreatic body. EUS-FNA was performed using a 25-gauge needle [Figure 2], leading to a cytological diagnosis of adenocarcinoma. Distal pancreatectomy with splenectomy was followed by adjuvant systemic chemotherapy with S-1 for 1 year. Histopathological diagnosis of the surgically resected specimen was well-differentiated tubular adenocarcinoma (T3N0M0, Stage IIA), and there was no remnant of cancer in intraoperative or pathological findings. CT and/or MRI were repeated performed every 3–5 months until 18 months after resection showed no evidence of tumor recurrence or metastasis.
Figure 1: Abdominal computed tomography: A mass lesion 10 mm in diameter in the pancreatic body (red arrow)

Click here to view
Figure 2: EUS-FNA was performed using a 25-gauge needle

Click here to view


The patient was subsequently brought to the emergency center of our hospital with hematemesis 22 months later after surgery. Upper gastrointestinal endoscopy was performed, and a Borrmann type 2-like lesion with bleeding was detected in the posterior wall of the gastric body [Figure 3] and confirmed as tubular adenocarcinoma from biopsy. CT revealed a gastric mass lesion located near the previous EUS-FNA puncture site [Figure 4]. No evidence of any other metastatic lesions was apparent, and the patient was scheduled for partial gastrectomy.
Figure 3: Upper gastrointestinal endoscopy image showing a Borrmann type 2-like lesion with bleeding in the posterior wall of the gastric body

Click here to view
Figure 4: Abdominal computed tomography: A gastric mass lesion located near the previous EUS-FNA puncture site (yellow arrows)

Click here to view


Intraoperatively, peritoneal disseminated lesions were confirmed, so the patient only underwent local resection of the stomach. Histological examination of the resected specimen revealed well-to-moderately differentiated tubular adenocarcinoma located from the mucosa to the serosa, with no evidence of cancer cells on the serosal surface [Figure 5]. KRAS mutation testing performed in both the pancreatic and gastric carcinomas demonstrated identical genetic alterations (G12V) in each specimen. The gastric lesion, therefore, indicated gastric wall implantation after the initial EUS-FNA for the pancreatic cancer.
Figure 5: Histological examination of the resected specimen revealed well-to-moderately differentiated tubular adenocarcinoma located from the mucosa to the serosa, with no evidence of cancer cells on the serosal surface

Click here to view


Seeding of pancreatic cancer after EUS-FNA has seldom been reported. Ikezawa et al. reported that EUS-FNA for pancreatic cancer did not significantly increase the risk of peritoneal carcinomatosis.[1] Needle tract seeding after surgery for pancreatic cancer has been reported in four patients since 2012.[2],[3],[4],[5] In all these cases, the cancer was localized to the pancreatic body, preoperative transgastric EUS-FNA was performed, and 8–28 months after surgery, metastases were identified in the gastric wall. Preoperative transgastric EUS-FNA in patients with resectable pancreatic body and tail cancer thus needs to be reconsidered in collaborative discussion with surgeons.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initial will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Ikezawa K, Uehara H, Sakai A, et al. Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. J Gastroenterol 2013;48:966-72.  Back to cited text no. 1
[PUBMED]    
2.
Katanuma A, Maguchi H, Hashigo S, et al. Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy 2012;44 Suppl 2 UCTN:E160-1.  Back to cited text no. 2
[PUBMED]    
3.
Minaga K, Kitano M, Yamashita Y. Surgically resected needle tract seeding following endoscopic ultrasound-guided fine-needle aspiration in pancreatic cancer. J Hepatobiliary Pancreat Sci 2015;22:708-9.  Back to cited text no. 3
    
4.
Sakurada A, Hayashi T, Ono M, et al. Acase of curatively resected gastric wall implantation of pancreatic cancer caused by endoscopic ultrasound-guided fine-needle aspiration. Endoscopy 2015;47 Suppl 1 UCTN:E198-9.  Back to cited text no. 4
[PUBMED]    
5.
Tomonari A, Katanuma A, Matsumori T, et al. Resected tumor seeding in stomach wall due to endoscopic ultrasonography-guided ne needle aspiration of pancreatic adenocarcinoma. World J Gastroenterol 2015;21:8458-61.  Back to cited text no. 5
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]


This article has been cited by
1 Prognostic significance of 14v-lymph node dissection to D2 dissection for lower-third gastric cancer
Chen Zheng,Zi-Ming Gao,An-Qi Sun,Hai-Bo Huang,Zhen-Ning Wang,Kai Li,Shan Gao
World Journal of Clinical Cases. 2019; 7(18): 2712
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed858    
    Printed8    
    Emailed0    
    PDF Downloaded126    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]